×
About 64,620 results

ALLMedicine™ Inflammatory Bowel Disease Center

Research & Reviews  30,707 results

Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonr...
https://doi.org/10.1093/ibd/izab032
Inflammatory Bowel Diseases; Verstockt S, Verstockt B et. al.

Feb 24th, 2021 - Oncostatin M (OSM) has been implicated in the pathogenesis of inflammatory bowel disease (IBD) and as a marker for nonresponsiveness to anti-tumor necrosis factor (TNF) therapy. We further unraveled the potential of OSM and related receptors as ma...

Clinical applications of artificial intelligence and machine learning-based methods in ...
https://doi.org/10.1111/jgh.15405
Journal of Gastroenterology and Hepatology; Cohen-Mekelburg S, Berry S et. al.

Feb 24th, 2021 - Our objective was to review and exemplify how selected applications of artificial intelligence (AI) might facilitate and improve inflammatory bowel disease (IBD) care and to identify gaps for future work in this field. IBD is highly complex and as...

Role of topical tacrolimus in the management of proctitis, perianal manifestations in C...
https://doi.org/10.1136/jim-2020-001699
Journal of Investigative Medicine : the Official Publicat... Salem G, Ding K et. al.

Feb 24th, 2021 - Several published studies have evaluated the safety and effectiveness of oral and intravenous tacrolimus for the management of patients with inflammatory bowel disease (IBD). However, little is known about the effectiveness of topical tacrolimus i...

Idiopathic bilateral ovarian vein thrombosis.
https://doi.org/10.1136/bcr-2020-238243
BMJ Case Reports; Christy J, Jarugula D et. al.

Feb 24th, 2021 - Ovarian vein thrombosis (OVT) is a condition most commonly associated with malignancy, hypercoagulable disorders, pelvic surgery, trauma, inflammatory bowel disease and the postpartum period. Idiopathic bilateral OVT is extremely rare. We report t...

Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker o...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874844
Mediators of Inflammation; Yoshimura T, Mitsuyama K et. al.

Feb 24th, 2021 - Studies on serum leucine-rich alpha-2 glycoprotein (LRG) in inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), are scarce; the methods for estimating disease activity are less established, particularly fo...

see more →

Guidelines  139 results

CANADIAN ASSOCIATION OF GASTROENTEROLOGY CLINICAL PRACTICE GUIDELINE FOR IMMUNIZATIONS ...
https://doi.org/10.1053/j.gastro.2020.12.079
Gastroenterology Benchimol EI, Tse F et. al.

Feb 22nd, 2021 - Patients with inflammatory bowel disease (IBD) may be at increased risk of some vaccine-preventable diseases (VPDs). The effectiveness and safety of vaccinations may be altered by immunosuppressive therapies or IBD itself. The aim of these guideli...

AGA Clinical Practice Update on Chemoprevention for Colorectal Neoplasia: Expert Review.
https://doi.org/10.1016/j.cgh.2021.02.014
Clinical Gastroenterology and Hepatology : the Official C... Liang PS, Shaukat A et. al.

Feb 13th, 2021 - The purpose of this expert review is to describe the role of medications for the chemoprevention of colorectal neoplasia. Neoplasia is defined as precancerous lesions (e.g., adenoma and sessile serrated lesion) or cancer. The scope of this review ...

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specifi...
https://doi.org/10.1111/jdv.16926
Journal of the European Academy of Dermatology and Venere... Nast A, Smith C et. al.

Feb 6th, 2021 - This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specific clini...

COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wa...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665406
Journal of Crohn's & Colitis; Ng SC, Mak JWY et. al.

Oct 21st, 2020 - Endoscopy is an essential component in the management of inflammatory bowel disease [IBD]. There is a risk of SARS-CoV-2 transmission during endoscopic procedures. The International Organization for the study of IBD [IOIBD] has developed 11 positi...

AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Pat...
https://doi.org/10.1053/j.gastro.2020.08.060
Gastroenterology Ananthakrishnan AN, Nguyen GC et. al.

Oct 4th, 2020 - AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review.|2020|Ananthakrishnan AN,Nguyen GC,Bernstein CN,|

see more →

Drugs  55 results see all →

Clinicaltrials.gov  31,937 results

Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonr...
https://doi.org/10.1093/ibd/izab032
Inflammatory Bowel Diseases; Verstockt S, Verstockt B et. al.

Feb 24th, 2021 - Oncostatin M (OSM) has been implicated in the pathogenesis of inflammatory bowel disease (IBD) and as a marker for nonresponsiveness to anti-tumor necrosis factor (TNF) therapy. We further unraveled the potential of OSM and related receptors as ma...

Clinical applications of artificial intelligence and machine learning-based methods in ...
https://doi.org/10.1111/jgh.15405
Journal of Gastroenterology and Hepatology; Cohen-Mekelburg S, Berry S et. al.

Feb 24th, 2021 - Our objective was to review and exemplify how selected applications of artificial intelligence (AI) might facilitate and improve inflammatory bowel disease (IBD) care and to identify gaps for future work in this field. IBD is highly complex and as...

Role of topical tacrolimus in the management of proctitis, perianal manifestations in C...
https://doi.org/10.1136/jim-2020-001699
Journal of Investigative Medicine : the Official Publicat... Salem G, Ding K et. al.

Feb 24th, 2021 - Several published studies have evaluated the safety and effectiveness of oral and intravenous tacrolimus for the management of patients with inflammatory bowel disease (IBD). However, little is known about the effectiveness of topical tacrolimus i...

Idiopathic bilateral ovarian vein thrombosis.
https://doi.org/10.1136/bcr-2020-238243
BMJ Case Reports; Christy J, Jarugula D et. al.

Feb 24th, 2021 - Ovarian vein thrombosis (OVT) is a condition most commonly associated with malignancy, hypercoagulable disorders, pelvic surgery, trauma, inflammatory bowel disease and the postpartum period. Idiopathic bilateral OVT is extremely rare. We report t...

Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker o...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874844
Mediators of Inflammation; Yoshimura T, Mitsuyama K et. al.

Feb 24th, 2021 - Studies on serum leucine-rich alpha-2 glycoprotein (LRG) in inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), are scarce; the methods for estimating disease activity are less established, particularly fo...

see more →

News  1,731 results

Macrophages That Heal Intestinal Inflammation Are Promising Target for IBD Therapy
https://www.medscape.com/viewarticle/946169

Feb 21st, 2021 - NEW YORK (Reuters Health) - A subset of macrophages, PTGER4+ (EP4+), are the major drivers of epithelial regeneration after intestinal inflammation and are potential targets for inflammatory bowel disease (IBD) therapy, researchers say. "Dysfuncti...

Ustekinumab Works Well in Ulcerative Colitis in the General Population
https://www.medscape.com/viewarticle/946043

Feb 18th, 2021 - NEW YORK (Reuters Health) - The monoclonal antibody ustekinumab (Stelara, Janssen) appears to be at least as effective against ulcerative colitis (UC) in real-world practice as it was in the clinical trials that led to its approval, according to n...

Checkpoint Inhibitor Safety in Preexisting Autoimmune Diseases
https://www.medscape.com/viewarticle/945979

Feb 16th, 2021 - Patients with advanced melanoma and preexisting autoimmune diseases (AIDs) who were treated with immune checkpoint inhibitors (ICIs) responded well and did not suffer more grade 3 or higher immune-related adverse events than patients without an AI...

Hirschsprung Disease Tied to Increased Risk of Inflammatory Bowel Disease
https://www.medscape.com/viewarticle/945801

Feb 15th, 2021 - (Reuters Health) - Children with Hirschsprung disease may be at increased risk for developing inflammatory bowel disease, a Canadian study suggests. Researchers examined data on 716 children diagnosed with Hirschsprung since 1991 in Ontario, as we...

Vedolizumab Looks Safer Than Anti-TNF Drugs in Older Adults With IBD
https://www.medscape.com/viewarticle/945729

Feb 11th, 2021 - A large analysis of Medicare data from all 50 states suggests that vedolizumab may be just as effective as anti–tumor necrosis factor (anti-TNF) agents in controlling inflammatory bowel disease (IBD) in patients aged over 65 years, with fewer infe...

see more →

Patient Education  51 results see all →